These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8970010)

  • 1. Clinical evaluation of global change in Alzheimer's disease: identifying consensus.
    Olin JT; Schneider LS; Doody RS; Clark CM; Ferris SH; Morris JC; Reisberg B; Schmitt FA
    J Geriatr Psychiatry Neurol; 1996 Oct; 9(4):176-80. PubMed ID: 8970010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study.
    Schneider LS; Olin JT; Doody RS; Clark CM; Morris JC; Reisberg B; Schmitt FA; Grundman M; Thomas RG; Ferris SH
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 2():S22-32. PubMed ID: 9236949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADCS Prevention Instrument Project: ADCS-clinicians' global impression of change scales (ADCS-CGIC), self-rated and study partner-rated versions.
    Schneider LS; Clark CM; Doody R; Ferris SH; Morris JC; Raman R; Reisberg B; Schmitt FA
    Alzheimer Dis Assoc Disord; 2006; 20(4 Suppl 3):S124-38. PubMed ID: 17135806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of rivastigmine transdermal patch and capsule on aspects of clinical global impression of change in Alzheimer's disease: a retrospective analysis.
    Cummings JL; Ferris SH; Farlow MR; Olin JT; Meng X
    Dement Geriatr Cogn Disord; 2010; 29(5):406-12. PubMed ID: 20502014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical global impressions in Alzheimer's clinical trials.
    Schneider LS; Olin JT
    Int Psychogeriatr; 1996; 8(2):277-88; discussion 288-90. PubMed ID: 8994897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A Brazilian Portuguese version for the ADCS-CGIC scale].
    Bertolucci PH; Nitrini R
    Arq Neuropsiquiatr; 2003 Sep; 61(3B):881-90. PubMed ID: 14595503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability study on the Japanese version of the Clinician's Interview-Based Impression of Change. Analysis of subscale items and 'clinician's impression'.
    Nakamura Y; Homma A; Kobune S; Tachibana Y; Satoh K; Takami I; Nagai S; Sakai M; Fukuta H; Matsuda H; Hashimoto H; Kusunoki T;
    Dement Geriatr Cogn Disord; 2007; 23(2):104-15. PubMed ID: 17135727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative Study.
    Mackell JA; Ferris SH; Mohs R; Schneider L; Galasko D; Whitehouse P; Schmitt F; Sano M; Thal LJ
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 2():S65-9. PubMed ID: 9236955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global measures: utility in defining and measuring treatment response in dementia.
    Reisberg B
    Int Psychogeriatr; 2007 Jun; 19(3):421-56. PubMed ID: 17480241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rivastigmine transdermal patch and capsule in Alzheimer's disease: influence of disease stage on response to therapy.
    Farlow MR; Grossberg GT; Meng X; Olin J; Somogyi M
    Int J Geriatr Psychiatry; 2011 Dec; 26(12):1236-43. PubMed ID: 22068922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials: overview and general results. The Alzheimer's Disease Cooperative Study.
    Ferris SH; Mackell JA; Mohs R; Schneider LS; Galasko D; Whitehouse PJ; Schmitt FA; Sano M; Thomas RG; Ernesto C; Grundman M; Schafer K; Thal LJ
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 2():S1-12. PubMed ID: 9236947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical progression of moderate-to-severe Alzheimer's disease and caregiver burden: a 12-month multicenter prospective observational study.
    Agüera-Ortiz L; Frank-García A; Gil P; Moreno A;
    Int Psychogeriatr; 2010 Dec; 22(8):1265-79. PubMed ID: 20849672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical study of lupron depot in the treatment of women with Alzheimer's disease: preservation of cognitive function in patients taking an acetylcholinesterase inhibitor and treated with high dose lupron over 48 weeks.
    Bowen RL; Perry G; Xiong C; Smith MA; Atwood CS
    J Alzheimers Dis; 2015; 44(2):549-60. PubMed ID: 25310993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The severe impairment battery: concurrent validity and the assessment of longitudinal change in Alzheimer's disease. The Alzheimer's Disease Cooperative Study.
    Schmitt FA; Ashford W; Ernesto C; Saxton J; Schneider LS; Clark CM; Ferris SH; Mackell JA; Schafer K; Thal LJ
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 2():S51-6. PubMed ID: 9236953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A longitudinal study of behavioral pathology across five levels of dementia severity in Alzheimer's disease: the CERAD Behavior Rating Scale for Dementia. The Alzheimer's Disease Cooperative Study.
    Patterson MB; Mack JL; Mackell JA; Thomas R; Tariot P; Weiner M; Whitehouse PJ
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 2():S40-4. PubMed ID: 9236951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.
    Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe.
    Feldman HH; Doody RS; Kivipelto M; Sparks DL; Waters DD; Jones RW; Schwam E; Schindler R; Hey-Hadavi J; DeMicco DA; Breazna A;
    Neurology; 2010 Mar; 74(12):956-64. PubMed ID: 20200346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADCS Prevention Instrument Project: overview and initial results.
    Ferris SH; Aisen PS; Cummings J; Galasko D; Salmon DP; Schneider L; Sano M; Whitehouse PJ; Edland S; Thal LJ;
    Alzheimer Dis Assoc Disord; 2006; 20(4 Suppl 3):S109-23. PubMed ID: 17135805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study.
    Mohs RC; Knopman D; Petersen RC; Ferris SH; Ernesto C; Grundman M; Sano M; Bieliauskas L; Geldmacher D; Clark C; Thal LJ
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 2():S13-21. PubMed ID: 9236948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 24-week, multicentre, open evaluation of the clinical effectiveness of the rivastigmine patch in patients with probable Alzheimer's disease.
    Articus K; Baier M; Tracik F; Kühn F; Preuss UW; Kurz A
    Int J Clin Pract; 2011 Jul; 65(7):790-6. PubMed ID: 21645184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.